↑Maciel RM, Kimura ET, Cerutti JM (Jan 2006). "[Pathogenesis of differentiated thyroid cancer (papillary and follicular)]". Arq Bras Endocrinol Metabol. 49 (5): 691–700. doi:10.1590/S0004-27302005000500009. PMID16444351.
Majima S, Kajino K, Fukuda T, et al. (2000). "A novel gene "Niban" upregulated in renal carcinogenesis: cloning by the cDNA-amplified fragment length polymorphism approach". Jpn. J. Cancer Res. 91 (9): 869–74. doi:10.1111/j.1349-7006.2000.tb01027.x. PMID11011112.
Sood R, Bonner TI, Makalowska I, et al. (2001). "Cloning and characterization of 13 novel transcripts and the human RGS8 gene from the 1q25 region encompassing the hereditary prostate cancer (HPC1) locus". Genomics. 73 (2): 211–22. doi:10.1006/geno.2001.6500. PMID11318611.
Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID14702039.
Gregory SG, Barlow KF, McLay KE, et al. (2006). "The DNA sequence and biological annotation of human chromosome 1". Nature. 441 (7091): 315–21. doi:10.1038/nature04727. PMID16710414.
Matsumoto F, Fujii H, Abe M, et al. (2007). "A novel tumor marker, Niban, is expressed in subsets of thyroid tumors and Hashimoto's thyroiditis". Hum. Pathol. 37 (12): 1592–600. doi:10.1016/j.humpath.2006.06.022. PMID16949643.